D-0622-2020 Class II Terminated
FDA drug recall D-0622-2020 was initiated by Medisca, Inc. on November 25, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated March 17, 2021). Affected quantity: 640,325 grams.
Recall Details
- Product Type
- Drugs
- Report Date
- December 25, 2019
- Initiation Date
- November 25, 2019
- Termination Date
- March 17, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 640,325 grams
Product Description
Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide
Code Information
Lot #156110 A-P Lot #153328 A-D Lot #161726 A-L